×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
QGEN – qiagen n.v. common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
QGEN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
04:12 pm
qgen
QIAGEN collaborates with McGill University to advance microbiome research [Yahoo! Finance]
Low
Report
QIAGEN collaborates with McGill University to advance microbiome research [Yahoo! Finance]
11/12
04:05 pm
qgen
QIAGEN collaborates with McGill University to advance microbiome research
Low
Report
QIAGEN collaborates with McGill University to advance microbiome research
11/12
10:41 am
qgen
Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation [Yahoo! Finance]
Low
Report
Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation [Yahoo! Finance]
11/11
10:47 am
qgen
Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock [Yahoo! Finance]
Low
Report
Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock [Yahoo! Finance]
11/8
10:59 am
qgen
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term [Yahoo! Finance]
11/8
02:37 am
qgen
Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements [Yahoo! Finance]
Low
Report
Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements [Yahoo! Finance]
11/7
11:47 am
qgen
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up [Yahoo! Finance]
Low
Report
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up [Yahoo! Finance]
11/7
11:47 am
qgen
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation? [Yahoo! Finance]
Low
Report
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/8
10:53 am
qgen
Form SC 13G QIAGEN N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SC 13G QIAGEN N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/8
06:02 am
qgen
Form 6-K QIAGEN N.V. For: Sep 30
Low
Report
Form 6-K QIAGEN N.V. For: Sep 30
11/8
06:02 am
qgen
Form 6-K QIAGEN N.V. For: Sep 30
Low
Report
Form 6-K QIAGEN N.V. For: Sep 30
11/8
06:01 am
qgen
Form 6-K QIAGEN N.V. For: Oct 31
Low
Report
Form 6-K QIAGEN N.V. For: Oct 31
11/7
11:46 am
qgen
Form SC 13G QIAGEN N.V. Filed by: BlackRock, Inc.
Low
Report
Form SC 13G QIAGEN N.V. Filed by: BlackRock, Inc.
10/21
04:13 pm
qgen
Form SC 13G QIAGEN N.V. Filed by: BlackRock, Inc.
Low
Report
Form SC 13G QIAGEN N.V. Filed by: BlackRock, Inc.
9/11
06:19 pm
qgen
Form 144 QIAGEN N.V. Filed by: Sackers Roland
Low
Report
Form 144 QIAGEN N.V. Filed by: Sackers Roland
9/4
04:35 pm
qgen
Form 6-K QIAGEN N.V. For: Sep 30
Low
Report
Form 6-K QIAGEN N.V. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/3
European shares rise 2% on stimulus hopes [Reuters]
16.8%
12/26 Qiagen NV (NYSE: QGEN) had its "underperform" rating re-affirmed by analysts at Bank of America Corp. They now have a $28.00 price target on the stock. 11.0%
11/15 QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strategic Alternatives 8.5%
11/13 Qiagen up 7% on rumored Thermo Fisher interest [Seeking Alpha] 6.2%
10/9 Qiagen NV (NYSE: QGEN) was downgraded by analysts at Kepler Capital Markets from a "hold" rating to a "reduce" rating. 5.4%
1/8 Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio 5.3%
2/4 Q4/2019 12/31/2019 EPS 0.480 ZacksConsensus 0.440 ActVsEst 0.040 - Beat 5.1%
11/6 QIAGEN Launches Novel NGS Workflow for Simultaneous DNA and RNA Analysis for Use in Cancer Profiling at 2019 AMP Annual Meeting 4.2%
2/26 QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2 3.9%
3/31 QIAGEN Receives U.S. FDA EUA for QIAstat-Dx test kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus 2.7%
12/26 Qiagen NV (NYSE: QGEN) had its "underperform" rating re-affirmed by analysts at Bank of America Corp. They now have a $28.00 price target on the stock. 11.0%
11/15 QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strategic Alternatives 8.5%
11/13 Qiagen up 7% on rumored Thermo Fisher interest [Seeking Alpha] 6.2%
10/9 Qiagen NV (NYSE: QGEN) was downgraded by analysts at Kepler Capital Markets from a "hold" rating to a "reduce" rating. 5.4%
1/8 Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio 5.3%
2/4 Q4/2019 12/31/2019 EPS 0.480 ZacksConsensus 0.440 ActVsEst 0.040 - Beat 5.1%
11/6 QIAGEN Launches Novel NGS Workflow for Simultaneous DNA and RNA Analysis for Use in Cancer Profiling at 2019 AMP Annual Meeting 4.2%
2/26 QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2 3.9%
3/31 QIAGEN Receives U.S. FDA EUA for QIAstat-Dx test kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus 2.7%
TOP News Decliners
10/7
QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests
-18.0%
5/6 Q1/2019 3/31/2019 EPS 0.270 ZacksConsensus 0.260 ActVsEst 0.010 - Beat -5.2%
3/11 Is This The Next Major Roadblock To The White House's Coronavirus Response? [zero hedge] -4.2%
7/24 Q2/2019 6/30/2019 EPS 0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.1%
11/18 Europe markets mostly higher as US-China trade talks dominate sentiment; Qiagen up 13% [CNBC] -3.2%
9/30 QIAGEN Launches Enhanced GeneGlobe Design & Analysis Hub, Combining Curated Knowledge, Content-based Assays and Analyses for Life Science Research -3.1%
2/5 Qiagen NV (NYSE: QGEN) had its "neutral" rating re-affirmed by analysts at Barclays PLC. -2.4%
3/18 Severe shortages of swabs and other supplies hamper testing [CNN] -2.2%
1/20 UPDATE 1-European shares dip as investors eye PMI data, ECB meeting [Reuters (UK)] -2.1%
8/20 Qiagen NV (NYSE: QGEN) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -1.9%
5/6 Q1/2019 3/31/2019 EPS 0.270 ZacksConsensus 0.260 ActVsEst 0.010 - Beat -5.2%
3/11 Is This The Next Major Roadblock To The White House's Coronavirus Response? [zero hedge] -4.2%
7/24 Q2/2019 6/30/2019 EPS 0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.1%
11/18 Europe markets mostly higher as US-China trade talks dominate sentiment; Qiagen up 13% [CNBC] -3.2%
9/30 QIAGEN Launches Enhanced GeneGlobe Design & Analysis Hub, Combining Curated Knowledge, Content-based Assays and Analyses for Life Science Research -3.1%
2/5 Qiagen NV (NYSE: QGEN) had its "neutral" rating re-affirmed by analysts at Barclays PLC. -2.4%
3/18 Severe shortages of swabs and other supplies hamper testing [CNN] -2.2%
1/20 UPDATE 1-European shares dip as investors eye PMI data, ECB meeting [Reuters (UK)] -2.1%
8/20 Qiagen NV (NYSE: QGEN) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -1.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: